Thursday, November 12, 2026 | 11am EST: FDA Meetings: Engaging Regulators Throughout Cell and Gene Therapy Development

X

Researchers Identify Multi-Action Drug Candidate For Type 2 Diabetes And Bone Disease

Posted on: in News | Life Science News | Pharma News
By:

Related Vitals

Sanofi Opens $925M Toronto Vaccine Facility
The investment expands Sanofi’s Toronto manufacturing footprint and will strengthen Canada’s domestic flu vaccine and pandemic-response capacity.
News

Northway Biotech Opens $70.8M Cell Therapy CDMO Facility in Vilnius, Lithuania
Vilnius, Lithuania, is home to Northway Biotech’s new cell therapy and personalized medicine manufacturing center.
News

From Oxfordshire to Wales: Where UK Life Sciences Investment Is Going in 2026
Cambridge is one of several UK life sciences hubs attracting new investment in R&D, manufacturing and biopharma infrastructure.
News

Bristol Myers Squibb Invests $2.3B in Houston Drug Manufacturing
Bristol Myers Squibb Houston manufacturing
News

Lilly and Resilience Invest $750M to Expand Medicine Production in Ohio
Lilly Resilience Ohio manufacturing investment
Pharmaville: Powering Life Sciences Location Strategy and FDI

Related Webinars

December 16, 2026

Explore Spatial Biology, Experimental Design and Spatial Proteomics
Hero - Desktop
December 14, 2026

Accelerate Medical Device Market Access With Home-Use Compliance
Hero - Desktop
December 17, 2026

Navigating Respiratory Clinical Trials: Ensuring Endpoint Integrity with Spirometry, HRCT and Patient-Centered Outcomes
Hero - Desktop
December 16, 2026

Emerging Therapeutic Modalities and Bioanalytical Strategies
Hero - Desktop
December 09, 2026

Predicting VHH-Fc Developability from Large-Scale IgG Data
Hero - Desktop